Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
PRA, a leading clinical research organization, today announced it has completed its 20th first in human trial with biologics. The milestone is the...
PRA, a leading clinical research organization, today announced that in addition to offering full-service bioanalytical capabilities in its Assen, The ...
PRA, a leading clinical research organization, today announced it has won two CRO Leadership Awards for quality. For its full-service offering, PRA...
PRA, a leading clinical research organization, today announced it has been named the 2014 "International Clinical Company of the Year" at the...
PRA, a leading clinical research organization, today announced it is a finalist in the category of Best Life Science Contract Research Organization...
PRA, a leading clinical research organization, today announced it has won the 2013 U.S. Clinical Researcher of the Year's "Clinical Company of the...
PRA, a leading clinical research organization, today announced its intent to acquire privately held CRI Lifetree, a specialized research organization....
PRA, a leading clinical research organization, today announces that 22 employees have been named finalists in the 2013 Clinical Researcher of the...
PRA, a leading Clinical Research Organization, announces that it won the 2012 US Clinical Researcher of the Year's "Clinical Company of the Year"...
PRA, a leading Clinical Research Organization, announces that one of our Late Phase experts will speak at the 15th annual CBI Registries and...
PRA, a leading Clinical Research Organization, announces the opening of a second office in China to accommodate our continued expansion in China and...
PRA, a leading Clinical Research Organization, announces that it is participating in a groundbreaking Alzheimer's disease study that could lead to...
PRA, una importante Organización de Investigaciones Clínicas, anuncia que está participando en un revolucionario estudio de la enfermedad de...
PRA, uma importante organização de pesquisa clínica, anuncia que está participando de um inédito estudo da doença de Alzheimer que poderia levar ao...
PRA, un organisme de recherche sous contrat (CRO) de premier plan, annonce sa participation à une étude révolutionnaire portant sur la maladie...
PRA, una organización de investigación clínica líder, anuncia su participación en un revolucionario estudio de la enfermedad de Alzheimer que podría...
PRA, ein führendes klinisches Forschungsinstitut, gibt bekannt, dass es sich an einer wegweisenden neuen Studie zur Alzheimer-Krankheit beteiligt....
PRA, a leading Clinical Research Organization, announces that two of our experts will speak at the DIA 48th Annual Meeting being held in Philadelphia ...
PRA, a leading Clinical Research Organization, announces the expansion of operations in The Netherlands (NL) and the United Kingdom (UK) to...
PRA, una importante Organización de Investigaciones Clínicas, anuncia un nuevo acuerdo con Amgen para una serie de estudios Fase III diseñados para...
PRA, a leading Clinical Research Organization, announces a new agreement with Amgen for a series of Phase III studies to develop several biosimilar...
A PRA, uma organização de pesquisa clínica líder, anuncia um novo acordo com a Amgen para uma série de estudos Fase III para desenvolver vários...
PRA, ein führendes Auftragsforschungsinstitut (CRO), meldete heute den Abschluss einer neuen Vereinbarung mit Amgen. Die Vereinbarung zielt auf die...
PRA, una destacada organización de investigación clínica (CRO), ha anunciado un nuevo acuerdo con Amgen para llevar a cabo una serie de estudios en...
PRA, un organisme de recherche sous contrat (CRO) de premier plan, a annoncé un nouvel accord avec Amgen en vue d'une série d'études de Phase III...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.